Overview of topical hemostatic agents and tissue adhesives
2023年12月14日 · HEMOSTATIC AGENTS. Topical hemostatic agents are used when surgical hemostasis is inadequate or impractical. The two main categories of topical hemostatic agents are physical agents, which promote hemostasis using a passive substrate, and biologically active agents, which enhance coagulation at the bleeding site (table 1). (See 'Physical agents ...
Topical hemostatic agents for managing bleeding - UpToDate
2021年12月15日 · Sponge, powder: Gelfilm, Gelfoam, Surgifoam, Gelfoam hemostasis kit (also contains human thrombin) 4 to 6 weeks: Infection, abscess or granuloma formation, fibrosis, clot disruption if sponge is removed [1] $ Oxidized regenerated cellulose: Plant: Mesh: Surgicel (Nu-Knit, Fibrillar, SNoW) 1 to 2 weeks Δ: Foreign body reaction, infection ...
UpToDate
Holster IL, van Beusekom HM, Kuipers EJ, et al. Effects of a hemostatic powder hemospray on coagulation and clot formation. Endoscopy 2015; 47:638. Yau AH, Ou G, Galorport C, et al. Safety and efficacy of Hemospray® in upper gastrointestinal bleeding. Can J Gastroenterol Hepatol 2014; 28:72.
UpToDate
Hemostatic spray is an endoscopic hemostatic powder for GI bleeding. This multicenter registry was created to collect data prospectively on the immediate endoscopic hemostasis of GI bleeding in patients with peptic ulcer disease when hemostatic spray is applied as endoscopic monotherapy, dual therapy, or rescue therapy.
Fibrin sealants - UpToDate
2022年10月4日 · Once Cohn fractionation led to the ability to generate highly concentrated fibrinogen preparations (in the 1960s), fibrin sealants were used to promote wound healing, skin grafting, and dural sealing; to provide hemostasis in microvascular surgery and parenchymal injury; and to serve as a matrix for bony chips and fragments in the repair of ...
RELATED TOPICS - UpToDate
Stanley AJ, Smith LA, Morris AJ. Use of hemostatic powder (Hemospray) in the management of refractory gastric variceal hemorrhage. Endoscopy 2013; 45 Suppl 2 UCTN:E86. Ibrahim M, El-Mikkawy A, Abdel Hamid M, et al. Early application of haemostatic powder added to standard management for oesophagogastric variceal bleeding: a randomised trial.
Overview of hemostasis - UpToDate
2024年1月19日 · Hemostasis is the process of blood clot formation at the site of vessel injury. When a blood vessel wall is disrupted, the hemostatic response must be quick, localized, and carefully regulated. Abnormal bleeding or thrombosis (ie, nonphysiologic blood clotting not required for hemostatic regulation) may occur when specific elements of these ...
UpToDate
90 PubMed | TI Endoscopic cyanoacrylate injection versus beta-blocker for secondary prophylaxis of gastric variceal bleed: a randomised controlled trial.
Overview of hemostasis - UpToDate
2024年1月19日 · Hemostasis is the process of blood clot formation at the site of vessel injury. When a blood vessel wall is disrupted, the hemostatic response must be quick, localized, and carefully regulated. Abnormal bleeding or thrombosis (ie, nonphysiologic blood clotting not required for hemostatic regulation) may occur when specific elements of these ...
Overview of topical hemostatic agents and tissue adhesives
2021年7月23日 · HEMOSTATIC AGENTS. Topical hemostatic agents are used when surgical hemostasis is inadequate or impractical. The two main categories of topical hemostatic agents are physical agents, which promote hemostasis using a passive substrate, and biologically active agents, which enhance coagulation at the bleeding site (table 1).